Amarin Has the Makings for a Gamechanging Product
When it comes to the biotech market, it’s not easy to show consistently strong gains. But Amarin’s (NASDAQ:AMRN) shareholders have come to expect a certain level of outperformance. Source: Pavel Kapysh / Shutterstock.com Just look at the average daily return for the past five years: a sizzling 84%! To put this in perspective, Netflix …
News story posted on 2019-12-15T10:37:00.0000000Z
